Directory
>
Andrew Schiermeier
Andrew Schiermeier
Chief Executive Officer | AvenCell
Cambridge, Massachusetts, United States
Andrew Schiermeier
Summary
Andrew Schiermeier is an accomplished executive with extensive experience in the biopharmaceutical and biotechnology sectors, currently serving as the President and CEO of AvenCell Therapeutics, Inc. His career spans over two decades, during which he has held various leadership roles in notable organizations such as Intellia Therapeutics and Merck Kgaa Darmstadt. With a strong academic background, including a Ph.D. from Harvard University, Andrew specializes in drug development, clinical trials, and oncology. He has a proven track record of driving innovation and strategy in both startups and established companies. His passion for advancing medical therapies reflects a commitment to improving patient outcomes through engineered cell therapies. Andrew's leadership style emphasizes cross-functional collaboration and strategic vision, making him a respected figure in the life sciences community.
Andrew Schiermeier
Work Experience
Chief Executive Officer at
AvenCell
August 2021 - Present
Chief Operating Officer at
Intellia Therapeutics, Inc.
July 2019 - August 2021
Executive Vice President, Head of Corporate Strategy & Development (Interim Head of Research) at
Intellia Therapeutics, Inc.
October 2018 - August 2021
Executive Vice President, Corporate Strategy at
Intellia Therapeutics, Inc.
April 2018 - October 2018
Senior Vice President, eXtellia at
Intellia Therapeutics, Inc.
January 2017 - April 2018
SVP, Global Head of Oncology & GM of Pfizer/Merck ImmunoOncology Alliance at
Merck KGaA, Darmstadt, Germany
May 2013 - January 2016
Chairman (former CEO) at
Medicine In Need
November 2007 - December 2014
Corporate Advisor at
Pathogenica
January 2012 - May 2013
Chief Operating Officer at
Aura Biosciences
January 2011 - May 2013
CEO at
Lantibio
February 2007 - January 2008
Vice President at
Paramount BioSciences
January 2006 - January 2008
Senior Manager at
EY
January 2005 - January 2006
Senior Engagement Manager at
Strategic Decisions Group (SDG)
January 1996 - January 2004
Senior Director at
Aventis Pharma
January 1999 - January 2002
Andrew Schiermeier
Education
Harvard University, Ph.D.
January 1992 - January 1997
College des Ingenieurs, Mba
January 1996 - January 1997
Stanford University, M.S.
January 1991 - January 1992
University of Cambridge, B.S.
January 1988 - January 1991
Washington University in St. Louis, Bs
January 1987 - January 1991
Frequently Asked Questions about Andrew Schiermeier
What is Andrew Schiermeier email address?
Andrew Schiermeier's primary email address is ******************@emdgroup.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Andrew Schiermeier work for?
Andrew Schiermeier is a Chief Executive Officer at AvenCell.
Where Andrew Schiermeier graduated from?
Andrew Schiermeier holds a degree in Engineering & Applied Math from Harvard University.
How can I directly contact Andrew Schiermeier?
To contact Andrew Schiermeier directly, you can use the email address ******************@emdgroup.com. Complete contact information is available upon registration with Muraena.
Who is Andrew Schiermeier?
Andrew Schiermeier is an accomplished executive with extensive experience in the biopharmaceutical and biotechnology sectors, currently serving as the President and CEO of AvenCell Therapeutics, Inc. His career spans over two decades, during which he has held various leadership roles in notable organizations such as Intellia Therapeutics and Merck Kgaa Darmstadt. With a strong academic background, including a Ph.D. from Harvard University, Andrew specializes in drug development, clinical trials, and oncology. He has a proven track record of driving innovation and strategy in both startups and established companies. His passion for advancing medical therapies reflects a commitment to improving patient outcomes through engineered cell therapies. Andrew's leadership style emphasizes cross-functional collaboration and strategic vision, making him a respected figure in the life sciences community.
Andrew`s contact details
******************@emdgroup.com
******************@intelliatx.com
******************@avencell.com
Colleagues
Founder, Board Director
Vice President Clinical Operations
VP, Head of US Research